相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Long-term dual antiplatelet therapy for secondary prevention of cardiovascular events in the subgroup of patients with previous myocardial infarction: a collaborative meta-analysis of randomized trials
Jacob A. Udell et al.
EUROPEAN HEART JOURNAL (2016)
Validation of BARC Bleeding Criteria in Patients With Acute Coronary Syndromes The TRACER Trial
Pascal Vranckx et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2016)
Left main or proximal left anterior descending coronary artery disease location identifies high-risk patients deriving potentially greater benefit from prolonged dual antiplatelet therapy duration
Francesco Costa et al.
EUROINTERVENTION (2016)
Anatomic Characteristics and Clinical Implications of Angiographic Coronary Thrombus Insights From a Patient-Level Pooled Analysis of SYNTAX, RESOLUTE, and LEADERS Trials
Carlos M. Campos et al.
Circulation-Cardiovascular Interventions (2015)
Duration of dual antiplatelet therapy after drug-eluting stent implantation: will we ever reach a consensus?
Marco Valgimigli et al.
EUROPEAN HEART JOURNAL (2015)
Impact of clinical presentation on ischaemic and bleeding outcomes in patients receiving 6-or 24-month duration of dual-antiplatelet therapy after stent implantation: a pre-specified analysis from the PRODIGY(Prolonging Dual-Antiplatelet Treatment After Grading Stent-Induced Intimal Hyperplasia) trial
Francesco Costa et al.
EUROPEAN HEART JOURNAL (2015)
Association of Spontaneous Bleeding and Myocardial Infarction With Long-Term Mortality After Percutaneous Coronary Intervention
Dhruv S. Kazi et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2015)
Long-Term Use of Ticagrelor in Patients with Prior Myocardial Infarction
Marc P. Bonaca et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Dual antiplatelet therapy duration after coronary stenting in clinical practice: results of an EAPCI survey
Marco Valgimigli et al.
EUROINTERVENTION (2015)
Optimal duration of dual antiplatelet therapy after percutaneous coronary intervention with drug eluting stents: meta-analysis of randomised controlled trials
Eliano Pio Navarese et al.
BMJ-BRITISH MEDICAL JOURNAL (2015)
Optimal duration of dual antiplatelet therapy after percutaneous coronary intervention with drug eluting stents: meta-analysis of randomised controlled trials
Eliano Pio Navarese et al.
BMJ-BRITISH MEDICAL JOURNAL (2015)
Applying novel methods to assess clinical outcomes: insights from the TRILOGY ACS trial
Jeffrey A. Bakal et al.
EUROPEAN HEART JOURNAL (2015)
Incremental Value of the CRUSADE, ACUITY, and HAS-BLED Risk Scores for the Prediction of Hemorrhagic Events After Coronary Stent Implantation in Patients Undergoing Long or Short Duration of Dual Antiplatelet Therapy
Francesco Costa et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2015)
2014 ESC/EACTS Guidelines on myocardial revascularization
Stephan Windecker et al.
EUROPEAN HEART JOURNAL (2014)
Twelve or 30 Months of Dual Antiplatelet Therapy after Drug-Eluting Stents
Laura Mauri et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Timing of Mortality After Severe Bleeding and Recurrent Myocardial Infarction in Patients With ST-Segment-Elevation Myocardial Infarction
Wouter J. Kikkert et al.
CIRCULATION-CARDIOVASCULAR INTERVENTIONS (2013)
Third Universal Definition of Myocardial Infarction
Kristian Thygesen et al.
CIRCULATION (2012)
The win ratio: a new approach to the analysis of composite endpoints in clinical trials based on clinical priorities
Stuart J. Pocock et al.
EUROPEAN HEART JOURNAL (2012)
Thrombin-Receptor Antagonist Vorapaxar in Acute Coronary Syndromes
Pierluigi Tricoci et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Refining clinical trial composite outcomes: An application to the Assessment of the Safety and Efficacy of a New Thrombolytic-3 (ASSENT-3) trial
Paul W. Armstrong et al.
AMERICAN HEART JOURNAL (2011)
Predictors of Bleeding and Time Dependence of Association of Bleeding With Mortality Insights From the Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition With Prasugrel-Thrombolysis in Myocardial Infarction 38 (TRITON-TIMI 38)
Willibald Hochholzer et al.
CIRCULATION (2011)
Standardized Bleeding Definitions for Cardiovascular Clinical Trials A Consensus Report From the Bleeding Academic Research Consortium
Roxana Mehran et al.
CIRCULATION (2011)
2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions
Glenn N. Levine et al.
CIRCULATION (2011)
Bleeding in acute coronary syndromes and percutaneous coronary interventions: position paper by the Working Group on Thrombosis of the European Society of Cardiology
Philippe Gabriel Steg et al.
EUROPEAN HEART JOURNAL (2011)
Bleeding complications with the P2Y12 receptor antagonists clopidogrel and ticagrelor in the PLATelet inhibition and patient Outcomes (PLATO) trial
Richard C. Becker et al.
EUROPEAN HEART JOURNAL (2011)
ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation
Christian W. Hamm et al.
EUROPEAN HEART JOURNAL (2011)
ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation
Christian W. Hamm et al.
TURK KARDIYOLOJI DERNEGI ARSIVI-ARCHIVES OF THE TURKISH SOCIETY OF CARDIOLOGY (2011)
Prognostic Modeling of Individual Patient Risk and Mortality Impact of Ischemic and Hemorrhagic Complications Assessment From the Acute Catheterization and Urgent Intervention Triage Strategy Trial
Stuart J. Pocock et al.
CIRCULATION (2010)
Associations of major bleeding and myocardial infarction with the incidence and timing of mortality in patients presenting with non-ST-elevation acute coronary syndromes: a risk model from the ACUITY trial
Roxana Mehran et al.
EUROPEAN HEART JOURNAL (2009)
Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndromes
Lars Wallentin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Periprocedural bleeding and 1-year outcome after percutaneous coronary interventions -: Appropriateness of including bleeding as a component of a quadruple end point
Gjin Ndrepepa et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2008)
Prasugrel versus clopidogrel in patients with acute coronary syndromes
Stephen D. Wiviott et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Impact of major bleeding on 30-day mortality and clinical outcomes in patients with acute coronary syndromes - An analysis from the ACUITY trial
Steven V. Manoukian et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2007)
Adverse impact of bleeding on prognosis in patients with acute coronary syndromes
John W. Eikelboom et al.
CIRCULATION (2006)
Impact of bleeding severity on clinical outcomes among patients with acute coronary syndromes
SV Rao et al.
AMERICAN JOURNAL OF CARDIOLOGY (2005)
Composite outcomes in randomized trials - Greater precision but with greater uncertainty?
N Freemantle et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2003)
分享论文
